SFN and early-onset autosomal dominant Alzheimer disease: Across a diverse spectrum (Table 1), SFN showcases its potential for neuroprotection in neurological disorders, such as traumatic brain injury, Parkinson’s disease, Alzheimer’s disease, and epilepsy, while also unveiling its promising anticancer attributes, including potential chemoprotective and chemotherapeutic applications.